1. Home
  2. BFH vs SUPN Comparison

BFH vs SUPN Comparison

Compare BFH & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

HOLD

Current Price

$83.41

Market Cap

3.5B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.17

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFH
SUPN
Founded
1996
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
BFH
SUPN
Price
$83.41
$51.17
Analyst Decision
Hold
Strong Buy
Analyst Count
15
5
Target Price
$80.64
$61.60
AVG Volume (30 Days)
582.6K
638.2K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
1.08%
N/A
EPS Growth
98.36
N/A
EPS
4.15
N/A
Revenue
$4,521,400,000.00
$392,755,000.00
Revenue This Year
$53.25
$22.70
Revenue Next Year
$3.53
$19.14
P/E Ratio
$20.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.17
$31.16
52 Week High
$99.13
$59.68

Technical Indicators

Market Signals
Indicator
BFH
SUPN
Relative Strength Index (RSI) 48.55 55.13
Support Level $82.47 $47.73
Resistance Level $99.13 $52.36
Average True Range (ATR) 2.81 2.13
MACD -0.80 0.25
Stochastic Oscillator 11.02 74.38

Price Performance

Historical Comparison
BFH
SUPN

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: